David-Alexandre C. Gros - Dec 20, 2021 Form 4 Insider Report for Eledon Pharmaceuticals, Inc. (ELDN)

Role
Chief Executive Officer, Director
Signature
/s/ Ryan A. Murr, as attorney-in-fact for David-Alexandre Gros
Stock symbol
ELDN
Transactions as of
Dec 20, 2021
Transactions value $
$8,960
Form type
4
Date filed
12/21/2021, 03:05 PM
Previous filing
Aug 19, 2021
Next filing
Feb 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELDN Common Stock Purchase $8.96K +2K +28.57% $4.48 9K Dec 20, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were purchased in an open market transaction in accordance with the Issuer's trading policies.